vTv Therapeutics Inc. (VTVT:NASDAQ) rocketted at $3.2, representing a gain of 52.4%. On Fri 07 Feb 20, VTVT:NASDAQ touched a New 2-Week Intraday Low of $1.99. The stock got featured on our News Catalysts scanner on Mon 10 Feb 20 at 07:46 AM in the 'BIOTECH' category. From Fri 17 Jan 20, the stock recorded 42.86% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About vTv Therapeutics Inc. (VTVT:NASDAQ)
vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes.
Top 10 Gainers:
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 1335.24%
- Precigen, Inc. (XON:NYSE), 293.2%
- Precigen, Inc. (XON:NASDAQ), 293.2%
- Taubman Centers, Inc. (TCO:NYSE), 53.22%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 52.38%
- Youdao, Inc. (DAO:NYSE), 39.48%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 34.58%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 32%
- Advaxis, Inc. (ADXS:NASDAQ), 28.71%
- Edgewell Personal Care Company (EPC:NYSE), 27.53%